1st Biotherapeutics Company

1STBIO is dedicated to developing breakthrough therapies with a key value to provide novel medicines to patients.

Total Funding: 14289918
Headquarters: Seongnam, Kyonggi-do, South Korea
Funding Status: Early Stage Venture
Employee Number: 1-10
Last Funding Type: Series B
Last Funding Date: 2020-07-30
Investors Number: 4
Founded Date: 2016-01-01
Industry: Neurodegeneration and Aging